Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Prothrombinex-VF
Active Ingredients: Factor II 500IU
Factor IX 500IU
Factor X 500IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia
Note: This consent is valid for two years from 3 December 2006.
Product: Tasmar
Active Ingredient: Tolcapone 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: F Hoffmann-La Roche AG, Basel, Switzerland
Note: This consent is valid for two years from 17 December 2006.
Dated this 26th day of October 2006.
KAREN MITCHELL, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).